The Acceptability and Feasibility of Reducing the Need for In-Clinic Follow-Up for First Trimester Medical Abortion in Moldova and Uzbekistan
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 2,400
- 试验地点
- 7
- 主要终点
- Continued, ongoing pregnancy
研究概览
简要总结
The purpose of this study is to determine whether an alternative method of follow-up after medical abortion is acceptable and feasible for use in Moldova and Uzbekistan.
详细描述
Medical abortion using mifepristone and misoprostol is a highly effective procedure, but access to it may be impeded by the fact that not all women can afford or want to return for a follow-up visit. This often results in a high loss to follow-up rate. Additionally, with medical abortions of those women who do return for follow-up, higher costs are borne by both the woman and the healthcare system.
This study compares two methods of follow-up after medical abortion: standard of care versus alternative follow-up. The former involves a routine clinic visit two weeks after misoprostol administration. The latter consists of a low-sensitivity pregnancy test and a self-administered questionnaire. Based on the results of the test and questionnaire, women may be flagged as needing in-clinic follow-up or discharged from the study if their abortion is complete.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 16 Years 至 55 Years（Child, Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Reproductive-age woman seeking a medical abortion
- •Woman in good general health
- •Woman with an intrauterine pregnancy less than or equal to 63 days gestation on the day of mifepristone administration
- •Woman able and willing to sign consent forms
- •Woman eligible for medical abortion according to clinician's assessment
- •Woman agreeing to be followed up with, by phone or at a clinic visit
排除标准
- •Woman with a pregnancy greater than 63 days gestation on the day of mifepristone administration
结局指标
主要结局
Continued, ongoing pregnancy
时间窗: 1 month
次要结局
- Percentage of women who return for follow-up(1 month)
- Percentage of women receiving other treatment for ongoing pregnancy(1 month)